Background We aimed to investigate the extent of pharmacokinetic drug interactions
between bosentan and a fixed combination of lopinavir/ritonavir. Methods This was a three …

Background. Boceprevir represents a new treatment option for hepatitis C (HCV)–infected
patients, including those with HCV/human immunodeficiency virus coinfection; however …

Background Fostemsavir is an oral prodrug of temsavir, a first‐in‐class attachment inhibitor
that binds HIV‐1 gp120, preventing initial HIV attachment and entry into host immune cells …

There is no parenteral formulation of the neuraminidase inhibitor oseltamivir, the most
widely used anti-influenza virus drug. Oseltamivir resistance is an increasing problem …

The aim of this study was to determine the impact of sex on the pharmacokinetics of
lopinavir/ritonavir. Interaction between lopinavir/ritonavir and tenofovir was also evaluated …

Objective: The primary aim of this study was to determine the bioequivalence of boceprevir,
an HCV protease inhibitor and etravirine, an HIV non–nucleoside reverse transcriptase …

Letermovir is a prophylactic agent for cytomegalovirus infection and disease in adult
cytomegalovirus‐seropositive recipients of allogeneic hematopoietic stem cell transplant. As …

The oral prodrug fostemsavir (GSK3684394, formerly BMS‐663068) is an antiretroviral
treatment for HIV‐1. Fostemsavir is metabolized to its active moiety, temsavir, a first‐in‐class …

Aims The aims of the present study were to compare the pharmacokinetics of oseltamivir
and its active antiviral metabolite oseltamivir carboxylate in obese and non‐obese …

A majority of people living with HIV (PLWH) now have access to HIV treatment with high
antiviral potency and favorable tolerability profile. However, in some treatment experienced …